[EN] QUINAZOLINONES DERIVATIVES FOR TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE, PREPARATION AND USE THEREOF<br/>[FR] DÉRIVÉS DE QUINAZOLINONES POUR LE TRAITEMENT DE LA STÉATOSE HÉPATIQUE NON ALCOOLIQUE, LEUR PRÉPARATION ET LEUR UTILISATION
申请人:COUNCIL SCIENT IND RES
公开号:WO2022003712A1
公开(公告)日:2022-01-06
The present invention described herein relates to a compound having Structure I for treating diseases and disorders for which inhibition or modulation of the Ubiquitin Ligase COP1 enzyme produces a physiologically beneficial response, in particular for the treatment of Non-Alcoholic Fatty Liver Disease (NAFLD). These compounds having Structure I arecapable of increasing the level of adipose triglyceride lipase (ATGL). Also provided is the process of preparing compounds having Structure I.
本发明描述了一种具有结构I的化合物,用于治疗通过抑制或调节泛素连接酶COP1酶产生生理上有益反应的疾病和紊乱,特别是用于治疗非酒精性脂肪肝病(NAFLD)。这些具有结构I的化合物能够增加脂肪三酸甘油酯脂解酶(ATGL)的水平。还提供了制备具有结构I的化合物的方法。